MC
VHAQ.RT

Meteora Capital’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Meteora Capital’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$510 – 366
2023
Q3 		$510 Hold
10,000
– – ﹤0.01% 364
2023
Q2 		$573 Buy
+10,000
New +$603 ﹤0.01% 374

Other funds holding VHAQ.RT

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return

Meteora Capital's VHAQ.RT Position: Q4 2023 in Review

Meteora Capital sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q4 2023, closing a stake of 10,000 shares — an estimated $510 sold.

Meteora Capital first reported a position in VHAQ.RT in Q2 2023 and held it in 2 quarters. The position peaked at $573 in Q2 2023. 28 funds tracked by Wall St. Rank hold VHAQ.RT as of Q4 2023.

  • Meteora Capital reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q4 2023 after selling out during the quarter.
  • Meteora Capital sold 10,000 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q4 2023, an estimated $510.
  • Meteora Capital first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q2 2023 and held it in 2 quarters.
  • Meteora Capital's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $573 in Q2 2023.
  • 28 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q4 2023.

Based on Meteora Capital's 13F filing for Q4 2023, filed 14 Feb 2024.